Recombinant collagen trimers from insect cells and yeast

Area of Science:

• Biochemistry
• Molecular Biology
• Biomaterials Science

Background:

• Over 28 collagen proteins are known, with many newly discovered collagens present in low tissue concentrations, hindering protein-level characterization.
• Animal-derived collagens are widely used as biomaterials and drug delivery systems but pose risks of allergic reactions and disease transmission.
• Existing recombinant expression systems in bacteria, yeast, and insect cells are inadequate for collagen production due to limitations in prolyl 4-hydroxylase activity.

Purpose of the Study:

• To address the limitations of current recombinant collagen production systems.
• To establish an efficient system for producing recombinant collagens with potential scientific and medical applications.
• To overcome the challenge of insufficient prolyl 4-hydroxylase activity in common expression hosts.

Main Methods:

• Investigated the role of prolyl 4-hydroxylase in collagen triple helix stability.
• Explored coexpression strategies for the alpha and beta subunits of human prolyl 4-hydroxylase.
• Tested recombinant expression in insect cells, yeast, and Escherichia coli.

Main Results:

• Prolyl 4-hydroxylase is crucial for collagen synthesis, as 4-hydroxyproline is essential for stable triple helix formation at 37°C.
• Previous in vitro attempts to assemble active prolyl 4-hydroxylase tetramers were unsuccessful.
• Active recombinant human prolyl 4-hydroxylase was successfully produced in insect cells, yeast, and E. coli via coexpression of its subunits.

Conclusions:

• Coexpression of human prolyl 4-hydroxylase subunits provides a viable method for producing active enzyme in various hosts.
• This advancement is critical for developing efficient recombinant collagen expression systems.
• The successful production of recombinant prolyl 4-hydroxylase opens avenues for novel biomaterials and therapeutic applications.